IMI - Institute for Medical Immunology
About Us
Research
Publications
Training
News
January 2007 - New tool for patients with type 1 diabetes
N-Acetylcysteine is a well known antioxidant drug which is used in patients with pulmonary diseases to facilitate expectorations, and also as therapy of paracetamol intoxication. A recent study performed by Claire Beuneu, Olivier Vosters and Valérie Verhasselt demonstrated that this drug reduces the procoagulant activity of human islet cells and might therefore be useful to improve the outcome of islet cell transplants. This work is published in the February 2007 issue of Diabetologia, the official journal of the European Association for the Study of Diabetes.

Related reference: Beuneu C, Vosters O, Ling Z, Pipeleers D, Pradier O, Goldman M, Verhasselt V. N-Acetylcysteine derivative inhibits procoagulant activity of human islet cells. Diabetologia 2007 : 50 : 343-347. View Abstract
To see Full News Archives, please click on the links below
> See news archives from July to December 2008
> See news archives from January to June 2008
> See news archives from July to December 2007
> See news archives from July to December 2006
> Search
Latest news
- February 15 : Biopark seminar with Susan Gasser> Read More
- February 28 : Bioké formation on flow cytometry> Read More
Recent publication in Leukemia> Read More
Recent publication in Nat Immunol> Read More
Recent publication in Hepatology> Read More
Recent publication in J Immunol> Read More
Recent publication in Am J Transplant> Read More
> Complete List of Seminars
> Upcoming Meetings and Events
> Full News Archives
Interesting Links
CMMI Center for Microscopy and Molecular Imaging

BioPark

BioWin Pôle de Compétitivité Santé de Wallon e
IBMM Institut de Biologie et de Médecine Moléculaires


GIGA Groupe Interdisciplinaire de Génoprotéomique Appliquée
Immunehealth provides Services to Biotech Companies and Biopharma in the field of Immunology    

 





Designed by Styrion-Kheper | Intuitive Extranet